Entry inhibitors
Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors
6
New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion
14
Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus
10
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
9
Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors
16
Viral Entry Inhibitors Targeted to the Membrane Site of Action
9
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
14
Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening
20
Lysosomotropic agents as HCV entry inhibitors
6
Molecular Determinants of Antiviral Potency of Paramyxovirus Entry Inhibitors
8
Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry
23
Characterization of resistance to a potent d peptide HIV entry inhibitor
12
Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100
10
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry
19
Non-Hepatic Adverse Effects of Antiretroviral Therapy for HIV Treatment and Care
6
Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site
32
Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
44
Will Multiple Coreceptors Need To Be Targeted by Inhibitors of Human Immunodeficiency Virus Type 1 Entry?
6
Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem
6
Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand foot and mouth diseases
13